Unknown

Dataset Information

0

Anti-gp120 minibody gene transfer to female genital epithelial cells protects against HIV-1 virus challenge in vitro.


ABSTRACT: Although cervico-vaginal epithelial cells of the female lower genital tract provide the initial defense system against HIV-1 infection, the protection is sometimes incomplete. Thus, enhancing anti-HIV-1 humoral immunity at the mucosal cell surface by local expression of anti-HIV-1 broadly neutralizing antibodies (BnAb) that block HIV-1 entry would provide an important new intervention that could slow the spread of HIV/AIDS.This study tested the hypothesis that adeno-associated virus (AAV)-BnAb gene transfer to cervico-vaginal epithelial cells will lead to protection against HIV-1. Accordingly, a recombinant AAV vector that encodes human b12 anti-HIV gp120 BnAb as a single-chain variable fragment Fc fusion (scFvFc), or "minibody" was constructed. The secreted b12 minibody was shown to be biologically functional in binding to virus envelope protein, neutralizing HIV-1 and importantly, blocking transfer and infectivity of HIV-1(bal) in an organotypic human vaginal epithelial cell (VEC) model. Furthermore, cervico-vaginal epithelial stem cells were found to be efficiently transduced by the optimal AAV serotype mediated expression of GFP.This study provides the foundation for a novel microbicide strategy to protect against sexual transmission of HIV-1 by AAV transfer of broadly neutralizing antibody genes to cervico-vaginal epithelial stem cells that could replenish b12 BnAb secreting cells through multiple menstrual cycles.

SUBMITTER: Abdel-Motal UM 

PROVIDER: S-EPMC3198777 | biostudies-literature | 2011

REPOSITORIES: biostudies-literature

altmetric image

Publications

Anti-gp120 minibody gene transfer to female genital epithelial cells protects against HIV-1 virus challenge in vitro.

Abdel-Motal Ussama M UM   Sarkis Phuong T N PT   Han Thomas T   Pudney Jeffery J   Anderson Deborah J DJ   Zhu Quan Q   Marasco Wayne A WA  

PloS one 20111021 10


<h4>Background</h4>Although cervico-vaginal epithelial cells of the female lower genital tract provide the initial defense system against HIV-1 infection, the protection is sometimes incomplete. Thus, enhancing anti-HIV-1 humoral immunity at the mucosal cell surface by local expression of anti-HIV-1 broadly neutralizing antibodies (BnAb) that block HIV-1 entry would provide an important new intervention that could slow the spread of HIV/AIDS.<h4>Methods and findings</h4>This study tested the hyp  ...[more]

Similar Datasets

| S-EPMC7642681 | biostudies-literature
| S-EPMC3433438 | biostudies-literature
| S-EPMC4596697 | biostudies-other
| S-EPMC6927651 | biostudies-literature
| S-EPMC3854988 | biostudies-literature
| S-EPMC4449736 | biostudies-literature
| S-EPMC2824512 | biostudies-literature
| S-EPMC6057065 | biostudies-literature
| S-EPMC3898223 | biostudies-literature
| S-EPMC4896633 | biostudies-literature